ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $12,826,000 | -2.7% | 317,301 | +38.5% | 3.63% | -1.3% |
| Q2 2015 | $13,188,000 | -9.9% | 229,154 | -0.3% | 3.67% | -4.4% |
| Q1 2015 | $14,638,000 | -14.4% | 229,887 | -17.0% | 3.84% | -12.8% |
| Q4 2014 | $17,094,000 | +42.0% | 276,870 | -10.7% | 4.41% | +22.6% |
| Q3 2014 | $12,034,000 | +6.2% | 309,934 | -5.8% | 3.60% | +14.3% |
| Q2 2014 | $11,335,000 | +26.8% | 329,034 | +59.0% | 3.14% | +22.0% |
| Q1 2014 | $8,942,000 | -20.9% | 206,934 | -27.1% | 2.58% | -23.1% |
| Q4 2013 | $11,308,000 | -3.7% | 283,834 | -9.3% | 3.35% | -8.6% |
| Q3 2013 | $11,743,000 | +34.1% | 312,834 | -4.0% | 3.67% | +37.9% |
| Q2 2013 | $8,755,000 | – | 325,834 | – | 2.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |